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Abstract
Over the past 15 years, malaria mortality has reduced by approximately 50%. However, malaria still causes more than
400,000 deaths annually, most of which occur in African children under 5 years of age. Significant advances in
understanding the pathogenesis of the disease provide a basis for future work to prevent severe malaria and its
complications. Herein, we provide an overview of advances in our understanding of severe malaria in African children over
the past 15 years, highlighting key complications and identifying priorities to further reduce malaria-associated mortality.
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Background
Plasmodium falciparum accounts for the majority of
malaria deaths, and is the predominant malaria species
in Africa (Fig. 1) [1]. Severe malaria (SM) is defined by
the detection of P. falciparum by microscopy or a rapid
diagnostic test and at least one criterion for severe disease
(impaired consciousness, respiratory distress, multiple con-
vulsions, prostration, shock, pulmonary edema, abnormal
bleeding, jaundice, severe anemia, hypoglycemia, acidosis,
hyperlactatemia, renal impairment, or hyperparasitemia)
[2]. Further, mortality can exceed 50% when multiple prog-
nostic factors are present [3].
SM is a multi-system disease characterized by a sys-
temic inflammatory response. A central feature in SM is
the sequestration of parasitized red blood cells (pRBCs)
in vascular beds, leading to impaired tissue perfusion
and lactic acidosis. Parasite ligand P. falciparum erythro-
cyte membrane protein-1 (PfEMP1) is expressed on the
pRBC membrane, where it binds to endothelial receptors
(e.g., CD36, soluble ICAM-1). Recently, the discovery of
endothelial protein C receptor (EPCR) as a novel and
conserved host receptor for PfEMP1 binding trans-
formed our understanding of SM pathogenesis (reviewed
by Bernabeu and Smith [4]), providing a link between endo-
thelial activation, inflammation, coagulation, and genetic
susceptibility to SM driven by host and parasite genetics.
Endothelial activation is common in SM and is associ-
ated with upregulated cellular adhesion molecules on
endothelium and their concomitant increase in plasma
through ectodomain cleavage [5]. The angiopoietin-Tie2
signaling pathway has an important association with dis-
ease severity and mortality in pediatric SM [6], and has
been implicated in blood–brain barrier breakdown and
death in experimental cerebral malaria (CM) [7].
Diverse forms of SM
SM is a multi-system disease driven by both host and para-
site factors. CM is the deadliest form of SM. Children with
CM often have malaria retinopathy, presenting with hemor-
rhages, retinal whitening, and vessel color changes, all of
which can be visualized by trained observers using ophthal-
moscopy. Interestingly, these changes mirror findings in
the brain at autopsy [8]. Further, the development of radio-
logic capacity in low-resource settings has led to advances
in our understanding of CM, with studies in Malawi show-
ing that cerebral edema predicts mortality in CM [9] and is
associated with EPCR-binding parasites [10].
Respiratory distress is a common form of SM best char-
acterized by deep acidotic breathing. Like other forms of
SM, respiratory distress is multifactorial. Impaired tissue
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perfusion secondary to pRBC sequestration and reduced
oxygen-carrying capacity in severe anemia contribute to
acidosis [11]. It is estimated that lactic acid contributes to
half the acid load in SM, with several other organic acids
being elevated in SM [12]. The kidney is important in acid
metabolism and excretion, and may be involved in acid-
osis in SM. Additionally, respiratory distress and acute
kidney injury (AKI) are linked by oxidative stress from the
destruction of pRBCs and the release of free heme [13].
Fifteen years ago, renal failure was considered a rare
complication in children with SM, yet it is now recognized
as one of the strongest predictors of mortality in SM [2].
The recognition that small changes in kidney function in-
dependently predict mortality in critical illness led to the
development of new guidelines to define AKI (Kidney Dis-
ease: Improving Global Outcomes, KDIGO) [14]. In a pro-
spective cohort of Ugandan children with SM, AKI was
common, occurring in 46% of young children with SM
[15]. Although data suggest AKI is related to reduced kid-
ney perfusion, additional studies are needed to evaluate
the spectrum of AKI over hospitalization to define the eti-
ology and pathophysiology of AKI in pediatric SM.
Severe malarial anemia (SMA) is the most common
form of SM. The etiology of SMA is complex, involving
increased destruction and removal of infected and unin-
fected RBCs, and reduced RBC production due to bone
marrow dyserythropoiesis (recently reviewed by White
[16]). SMA can occur in the absence of other SM compli-
cations in children with repeated or inadequately treated
infections, and mortality is low with appropriate transfu-
sion [11]. However, SMA is not benign – it contributes to
significant long-term morbidity, including impaired neu-
rocognitive functioning [17], repeated hospitalizations,
and post-discharge mortality [16].
Fig. 1 Severe malaria and its complications
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Long-term complications associated with SM
One in four children prospectively enrolled in studies
with CM develop neurocognitive impairments that per-
sist at least 2 years following exposure [18]. Retrospect-
ive studies suggest impairments may last 8 years or
longer, and may include behavioral problems, mental
health issues, and the development of epilepsy (reviewed
by Idro et al. [19]). Children with SMA have long-term
complications related to cognition [17]; therefore, given
the huge burden of SMA, it may be a significant con-
tributor to neurocognitive impairment in African chil-
dren. Nevertheless, the mechanisms leading to brain
injury and subsequent neurocognitive complications due
to SM are not well understood. In particular, questions
remain about how an intravascular parasite can lead to
such a breadth of complications, and why these compli-
cations are only observed in a fraction of the population
with SM [19].
Elevated cerebrospinal fluid (CSF) levels of TNF-α are
associated with prolonged coma duration, neurologic
deficits, and long-term cognitive deficits in children over
5 years [20]. A strong correlation of the CSF-to-plasma
TNF-α ratio and CSF-to-plasma albumin index (an indi-
cator of blood–brain barrier impairment) suggest a de-
gree of permeability across the blood–brain barrier [20].
Metabolites of the kynurenine pathway are markedly ele-
vated in the CSF of children with CM and have been as-
sociated with prolonged coma and impaired attention in
children over 5 years [19, 21]. Axonal injury marker tau
is elevated in CSF of children with CM and is associated
with acute neurologic deficits (reviewed by Idro et al.
[19]). Our studies in Ugandan children with CM suggest
elevated CSF-tau is associated with prolonged coma dur-
ation and long-term cognitive impairment, particularly
in children over 5 years, and may be mediated in part by
blood–brain barrier impairment. Additional studies are
needed to delineate the mechanisms leading to neuro-
cognitive complications in SM, particularly in children
without overt clinical signs suggestive of brain injury.
Conclusions
Figure 1 outlines the burden of SM and the ways in which
this burden could be lessened in the future. Prevention of
SM and its complications will require better implementa-
tion of known preventive measures, including primary
measures to prevent infection (e.g., insecticide-treated
bed-nets) and secondary measures to prevent severe dis-
ease such as rapid access to care, use of appropriate mal-
aria diagnostics, and effective treatment of uncomplicated
malaria. Increased knowledge of clinical prognostic signs
and implementation of point-of-care tools to identify chil-
dren at risk of clinical deterioration or death could facili-
tate directed use of intrarectal artesunate in primary
health centers prior to referral and transport to tertiary
centers. Better knowledge on pRBC and endothelial cell
interactions – in particular ICAM-1 and EPCR-binding
parasites – may lead to novel vaccine targets. Further, re-
search on the etiology and pathogenesis of AKI in SM, an
important complication that remains poorly understood,
is critical. Point-of-care tools to facilitate prompt recogni-
tion of AKI, development of resource-appropriate kidney
care guidelines, and early referral to higher levels of care
could reduce the long-term impact of AKI on children’s
health. Finally, a better understanding of the pathogenesis
of neurodevelopmental complications, as well as the
long-term health costs of these complications, may lead to
interventions to reduce neurodevelopmental disability in
survivors. In the long run, investment in both primary
malaria prevention and better management of SM will
lead to substantial health benefits for children in
sub-Saharan Africa.
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